Progyny Posts 32c EPS for Third Quarter
PGNY sits 87% above its 52-week low of $16.1.
Summary
Progyny reported third-quarter EPS of 32 cents, per the Dow Jones newswire flash, and revenue of $341.3M, up 8.9%. The company also raised its 2026 guidance midpoint. Context matters here: the company posted better-than-expected Q2 results and raised full-year guidance in August, so the bar was set high. Watch for any updated outlook, plus the earnings call, to see whether the Q2 momentum held.
At the time of this announcement, PGNY was trading at $30.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $16.10 to $33.07. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.